SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2gzl'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HSH_C_MK1C402_1 (HIV-II PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 ILE A 98 GLY A 145 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.93A	1hshC-2gzlA: undetectable	1hshC-2gzlA: 21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HSH_C_MK1C402_2 (HIV-II PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 8	ALA A 40 ILE A 99 PRO A 103 ILE A 18 ILE A 20	None	1.42A	1hshD-2gzlA: undetectable	1hshD-2gzlA: 21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HXW_B_RITB301_1 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 9	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.99A	1hxwA-2gzlA: undetectable	1hxwA-2gzlA: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SDU_B_MK1B902_2 (PROTEASE RETROPEPSIN)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	1.07A	1sduB-2gzlA: undetectable	1sduB-2gzlA: 19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B60_B_RITB100_1 (GAG-POL POLYPROTEIN)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 ILE A 98 GLY A 145 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.80A	2b60A-2gzlA: undetectable	2b60A-2gzlA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BR4_B_SAMB301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 6 CYH A 148 ASP A 46 ALA A 43 ALA A 40	None	1.20A	2br4B-2gzlA: undetectable	2br4B-2gzlA: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HS1_A_017A201_1 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.92A	2hs1A-2gzlA: undetectable	2hs1A-2gzlA: 19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IEN_B_017B402_2 (PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.90A	2ienB-2gzlA: undetectable	2ienB-2gzlA: 19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2M9Q_B_BEZB251_0 (SERINE PROTEASE INHIBITOR SERINE PROTEASE SUBUNIT NS2B, SERINE PROTEASE NS3)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 9	ILE A 18 ILE A 20 PHE A 12 VAL A 39 ALA A 33	None	1.13A	2m9qA-2gzlA: undetectable	2m9qA-2gzlA: 23.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QMJ_A_ACRA1001_1 (MALTASE-GLUCOAMYLASE , INTESTINAL)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	ASP A 38 ILE A 19 ASP A 72 ASP A 119 ALA A 117	None	1.19A	2qmjA-2gzlA: undetectable	2qmjA-2gzlA: 11.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RKF_A_AB1A501_2 (PROTEASE RETROPEPSIN)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	6 / 12	GLY A 37 ASP A 8 ILE A 98 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None None	1.18A	2rkfB-2gzlA: undetectable	2rkfB-2gzlA: 23.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RKG_B_AB1B501_1 (PROTEASE RETROPEPSIN)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	6 / 12	GLY A 37 ASP A 8 ILE A 98 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None None	1.10A	2rkgA-2gzlA: undetectable	2rkgA-2gzlA: 24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RKG_B_AB1B501_2 (PROTEASE RETROPEPSIN)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 ILE A 98 GLY A 145 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.83A	2rkgB-2gzlA: undetectable	2rkgB-2gzlA: 24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CYW_A_017A201_2 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.94A	3cywB-2gzlA: undetectable	3cywB-2gzlA: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKT_D_017D200_2 (PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 11	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.95A	3ektD-2gzlA: undetectable	3ektD-2gzlA: 22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FHJ_E_TRPE1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 10	GLY A 121 GLN A 85 ASP A 119 ILE A 116 VAL A 127	None	1.34A	3fhjE-2gzlA: undetectable	3fhjE-2gzlA: 18.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FI0_O_TRPO1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 9	GLY A 121 GLN A 85 ASP A 119 ILE A 116 VAL A 127	None	1.31A	3fi0O-2gzlA: undetectable	3fi0O-2gzlA: 18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LZS_A_017A200_1 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.94A	3lzsA-2gzlA: undetectable	3lzsA-2gzlA: 24.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LZS_A_017A200_2 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.97A	3lzsB-2gzlA: undetectable	3lzsB-2gzlA: 24.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LZU_A_017A200_1 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.96A	3lzuA-2gzlA: undetectable	3lzuA-2gzlA: 24.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OXX_A_DR7A100_1 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	1.04A	3oxxA-2gzlA: undetectable	3oxxA-2gzlA: 19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PWM_B_017B402_2 (PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.88A	3pwmB-2gzlA: undetectable	3pwmB-2gzlA: 19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3S54_B_017B201_2 (PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	6 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 25 ILE A 20	None ZN A 900 ( 2.4A) None None None None	1.06A	3s54B-2gzlA: undetectable	3s54B-2gzlA: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTP_A_017A201_1 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 10	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.96A	3ttpA-2gzlA: undetectable	3ttpA-2gzlA: 22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTP_A_017A201_2 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 10	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.98A	3ttpB-2gzlA: undetectable	3ttpB-2gzlA: 22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HLA_A_017A200_1 (PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.89A	4hlaA-2gzlA: undetectable	4hlaA-2gzlA: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D4N_A_ACTA202_0 (NITROGEN REGULATORY PROTEIN P-II)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	4 / 4	VAL A 23 GLY A 22 ARG A 74 VAL A 114	None	1.28A	5d4nA-2gzlA: undetectable 5d4nB-2gzlA: undetectable	5d4nA-2gzlA: 21.30 5d4nB-2gzlA: 21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E5K_B_017B201_1 (HIV-1 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	6 / 12	GLY A 37 ASP A 8 ILE A 98 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None None	1.06A	5e5kA-2gzlA: undetectable	5e5kA-2gzlA: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 11	THR A 134 THR A 133 THR A 132 ARG A 142 GLY A 143	GPP A 903 (-3.8A) None None GPP A 903 (-3.0A) None	1.48A	5l66H-2gzlA: undetectable 5l66N-2gzlA: undetectable	5l66H-2gzlA: 23.27 5l66N-2gzlA: 20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MUR_B_PFLB407_1 (PROTON-GATED ION CHANNEL)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	4 / 7	TYR A 27 ILE A 18 ILE A 25 ILE A 98	None	0.91A	5murB-2gzlA: undetectable	5murB-2gzlA: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OM2_B_DXTB501_1 (ALPHA-1-ANTICHYMOTRY PSIN)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 9	VAL A 39 LEU A 31 ALA A 11 PHE A 12 ILE A 20	None	1.02A	5om2A-2gzlA: undetectable 5om2B-2gzlA: undetectable	5om2A-2gzlA: 23.48 5om2B-2gzlA: 12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5T8H_B_478B401_1 (PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	GLY A 37 ASP A 8 GLY A 145 PRO A 103 ILE A 20	None ZN A 900 ( 2.4A) None None None	0.91A	5t8hA-2gzlA: undetectable	5t8hA-2gzlA: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YOD_B_BEZB201_0 (NS3 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	4 / 5	HIS A 42 ALA A 71 SER A 35 GLY A 37	ZN A 900 (-3.1A) 2AA A 901 (-3.6A) 2AA A 901 (-3.7A) None	1.25A	5yodB-2gzlA: undetectable	5yodB-2gzlA: 22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YOD_D_BEZD201_0 (NS3 PROTEASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	4 / 5	HIS A 42 ALA A 71 SER A 35 GLY A 37	ZN A 900 (-3.1A) 2AA A 901 (-3.6A) 2AA A 901 (-3.7A) None	1.23A	5yodD-2gzlA: undetectable	5yodD-2gzlA: 22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6N91_A_DCFA401_0 (ADENOSINE DEAMINASE)	2gzl	2-C-METHYL-D-ERYTHRI TOL 2,4-CYCLODIPHOSPHATE SYNTHASE (Escherichia coli)	5 / 12	ASP A 8 LEU A 76 SER A 35 ASP A 56 ASP A 46	ZN A 900 ( 2.4A) 2AA A 901 (-3.9A) 2AA A 901 (-3.7A) 2AA A 901 (-3.0A) None	1.27A	6n91A-2gzlA: undetectable	6n91A-2gzlA: 21.43

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HSH_C_MK1C402_1","HIV-II PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;ILE A  98;GLY A 145;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.93A","1hshC-2gzlA:undetectable","1hshC-2gzlA:21.47"],["1HSH_C_MK1C402_2","HIV-II PROTEASE;HIV-II PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"ALA A  40;ILE A  99;PRO A 103;ILE A  18;ILE A  20","None","1.42A","1hshD-2gzlA:undetectable","1hshD-2gzlA:21.47"],["1HXW_B_RITB301_1","HIV-1 PROTEASE;HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.99A","1hxwA-2gzlA:undetectable","1hxwA-2gzlA:20.73"],["1SDU_B_MK1B902_2","PROTEASE RETROPEPSIN","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","1.07A","1sduB-2gzlA:undetectable","1sduB-2gzlA:19.88"],["2B60_B_RITB100_1","GAG-POL POLYPROTEIN;GAG-POL POLYPROTEIN","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;ILE A  98;GLY A 145;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.80A","2b60A-2gzlA:undetectable","2b60A-2gzlA:20.00"],["2BR4_B_SAMB301_0","CEPHALOSPORIN HYDROXYLASE CMCI","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A   6;CYH A 148;ASP A  46;ALA A  43;ALA A  40","None","1.20A","2br4B-2gzlA:undetectable","2br4B-2gzlA:22.89"],["2HS1_A_017A201_1","HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.92A","2hs1A-2gzlA:undetectable","2hs1A-2gzlA:19.88"],["2IEN_B_017B402_2","PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.90A","2ienB-2gzlA:undetectable","2ienB-2gzlA:19.88"],["2M9Q_B_BEZB251_0","SERINE PROTEASE INHIBITOR;SERINE PROTEASE SUBUNIT NS2B, SERINE PROTEASE NS3","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"ILE A  18;ILE A  20;PHE A  12;VAL A  39;ALA A  33","None","1.13A","2m9qA-2gzlA:undetectable","2m9qA-2gzlA:23.25"],["2QMJ_A_ACRA1001_1","MALTASE-GLUCOAMYLASE, INTESTINAL","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"ASP A  38;ILE A  19;ASP A  72;ASP A 119;ALA A 117","None","1.19A","2qmjA-2gzlA:undetectable","2qmjA-2gzlA:11.39"],["2RKF_A_AB1A501_2","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",6,"GLY A  37;ASP A   8;ILE A  98;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None;None","1.18A","2rkfB-2gzlA:undetectable","2rkfB-2gzlA:23.94"],["2RKG_B_AB1B501_1","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",6,"GLY A  37;ASP A   8;ILE A  98;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None;None","1.10A","2rkgA-2gzlA:undetectable","2rkgA-2gzlA:24.48"],["2RKG_B_AB1B501_2","PROTEASE RETROPEPSIN","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;ILE A  98;GLY A 145;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.83A","2rkgB-2gzlA:undetectable","2rkgB-2gzlA:24.48"],["3CYW_A_017A201_2","HIV-1 PROTEASE;HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.94A","3cywB-2gzlA:undetectable","3cywB-2gzlA:19.76"],["3EKT_D_017D200_2","PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.95A","3ektD-2gzlA:undetectable","3ektD-2gzlA:22.62"],["3FHJ_E_TRPE1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A 121;GLN A  85;ASP A 119;ILE A 116;VAL A 127","None","1.34A","3fhjE-2gzlA:undetectable","3fhjE-2gzlA:18.81"],["3FI0_O_TRPO1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A 121;GLN A  85;ASP A 119;ILE A 116;VAL A 127","None","1.31A","3fi0O-2gzlA:undetectable","3fi0O-2gzlA:18.90"],["3LZS_A_017A200_1","HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.94A","3lzsA-2gzlA:undetectable","3lzsA-2gzlA:24.62"],["3LZS_A_017A200_2","HIV-1 PROTEASE;HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.97A","3lzsB-2gzlA:undetectable","3lzsB-2gzlA:24.62"],["3LZU_A_017A200_1","HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.96A","3lzuA-2gzlA:undetectable","3lzuA-2gzlA:24.62"],["3OXX_A_DR7A100_1","HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","1.04A","3oxxA-2gzlA:undetectable","3oxxA-2gzlA:19.75"],["3PWM_B_017B402_2","PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.88A","3pwmB-2gzlA:undetectable","3pwmB-2gzlA:19.88"],["3S54_B_017B201_2","PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",6,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  25;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None;None","1.06A","3s54B-2gzlA:undetectable","3s54B-2gzlA:21.12"],["3TTP_A_017A201_1","HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.96A","3ttpA-2gzlA:undetectable","3ttpA-2gzlA:22.30"],["3TTP_A_017A201_2","HIV-1 PROTEASE;HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.98A","3ttpB-2gzlA:undetectable","3ttpB-2gzlA:22.30"],["4HLA_A_017A200_1","PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.89A","4hlaA-2gzlA:undetectable","4hlaA-2gzlA:20.73"],["5D4N_A_ACTA202_0","NITROGEN REGULATORY PROTEIN P-II","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",4,"VAL A  23;GLY A  22;ARG A  74;VAL A 114","None","1.28A","5d4nA-2gzlA:undetectable;5d4nB-2gzlA:undetectable","5d4nA-2gzlA:21.30;5d4nB-2gzlA:21.30"],["5E5K_B_017B201_1","HIV-1 PROTEASE;HIV-1 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",6,"GLY A  37;ASP A   8;ILE A  98;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None;None","1.06A","5e5kA-2gzlA:undetectable","5e5kA-2gzlA:21.12"],["5L66_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"THR A 134;THR A 133;THR A 132;ARG A 142;GLY A 143","GPP A 903 (-3.8A);None;None;GPP A 903 (-3.0A);None","1.48A","5l66H-2gzlA:undetectable;5l66N-2gzlA:undetectable","5l66H-2gzlA:23.27;5l66N-2gzlA:20.51"],["5MUR_B_PFLB407_1","PROTON-GATED ION CHANNEL","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",4,"TYR A  27;ILE A  18;ILE A  25;ILE A  98","None","0.91A","5murB-2gzlA:undetectable","5murB-2gzlA:21.14"],["5OM2_B_DXTB501_1","ALPHA-1-ANTICHYMOTRYPSIN;ALPHA-1-ANTICHYMOTRYPSIN","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"VAL A  39;LEU A  31;ALA A  11;PHE A  12;ILE A  20","None","1.02A","5om2A-2gzlA:undetectable;5om2B-2gzlA:undetectable","5om2A-2gzlA:23.48;5om2B-2gzlA:12.50"],["5T8H_B_478B401_1","PROTEASE;PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"GLY A  37;ASP A   8;GLY A 145;PRO A 103;ILE A  20","None; ZN A 900 ( 2.4A);None;None;None","0.91A","5t8hA-2gzlA:undetectable","5t8hA-2gzlA:21.12"],["5YOD_B_BEZB201_0","NS3 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",4,"HIS A  42;ALA A  71;SER A  35;GLY A  37"," ZN A 900 (-3.1A);2AA A 901 (-3.6A);2AA A 901 (-3.7A);None","1.25A","5yodB-2gzlA:undetectable","5yodB-2gzlA:22.75"],["5YOD_D_BEZD201_0","NS3 PROTEASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",4,"HIS A  42;ALA A  71;SER A  35;GLY A  37"," ZN A 900 (-3.1A);2AA A 901 (-3.6A);2AA A 901 (-3.7A);None","1.23A","5yodD-2gzlA:undetectable","5yodD-2gzlA:22.75"],["6N91_A_DCFA401_0","ADENOSINE DEAMINASE","2gzl","2-C-METHYL-D-ERYTHRITOL 2,4-CYCLODIPHOSPHATE SYNTHASE","Escherichia coli",5,"ASP A   8;LEU A  76;SER A  35;ASP A  56;ASP A  46"," ZN A 900 ( 2.4A);2AA A 901 (-3.9A);2AA A 901 (-3.7A);2AA A 901 (-3.0A);None","1.27A","6n91A-2gzlA:undetectable","6n91A-2gzlA:21.43"]]